Abstract

Tropomodulins (Tmods) are F-actin pointed end capping proteins that interact with tropomyosins (TMs) and cap TM-coated filaments with higher affinity than TM-free filaments. Here, we tested whether differences in recognition of TM or actin isoforms by Tmod1 and Tmod3 contribute to the distinct cellular functions of these Tmods. We found that Tmod3 bound ~5-fold more weakly than Tmod1 to α/βTM, TM5b, and TM5NM1. However, surprisingly, Tmod3 was as effective as Tmod1 at capping pointed ends of skeletal muscle α-actin (αsk-actin) filaments coated with α/βTM, TM5b, or TM5NM1. Tmod3 only capped TM-coated αsk-actin filaments more weakly than Tmod1 in the presence of recombinant αTM2, which is unacetylated at its NH2 terminus, binds F-actin weakly, and has a disabled Tmod-binding site. Moreover, both Tmod1 and Tmod3 were similarly effective at capping pointed ends of platelet β/cytoplasmic γ (γcyto)-actin filaments coated with TM5NM1. In the absence of TMs, both Tmod1 and Tmod3 had similarly weak abilities to nucleate β/γcyto-actin filament assembly, but only Tmod3 could sequester cytoplasmic β- and γcyto-actin (but not αsk-actin) monomers and prevent polymerization under physiological conditions. Thus, differences in TM binding by Tmod1 and Tmod3 do not appear to regulate the abilities of these Tmods to cap TM-αsk-actin or TM-β/γcyto-actin pointed ends and, thus, are unlikely to determine selective co-assembly of Tmod, TM, and actin isoforms in different cell types and cytoskeletal structures. The ability of Tmod3 to sequester β- and γcyto-actin (but not αsk-actin) monomers in the absence of TMs suggests a novel function for Tmod3 in regulating actin remodeling or turnover in cells.

Highlights

  • Tropomodulins (Tmods) cap pointed ends of actin filaments in a tropomyosin (TM)-dependent manner

  • Sarcomeric and Cytoskeletal TMs Bind to ␣sk-Actin Filaments with Varying Affinities—TM isoforms bind to ␣sk-actin filaments with distinct affinities [13], affecting TM polymerization along F-actin and the probability that the terminal TM will associate with the pointed end [52, 53]

  • The conclusion that Tmod1 is a stronger TM binder than Tmod3 is consistent with published measurements of Kd values for the TM-binding Site 1 and Site 2 fragments of Tmod1 and Tmod3 binding to N-terminal ␣TM1a, ␣TM1b, and ␥TM1b synthetic peptides corresponding to the ␣/␤TM, TM5b, and TM5NM1 proteins, respectively, tested in our study

Read more

Summary

Background

Tropomodulins (Tmods) cap pointed ends of actin filaments in a tropomyosin (TM)-dependent manner. Tmod was as effective as Tmod at capping pointed ends of skeletal muscle ␣-actin (␣sk-actin) filaments coated with ␣/␤TM, TM5b, or TM5NM1. Tmod only capped TM-coated ␣sk-actin filaments more weakly than Tmod in the presence of recombinant ␣TM2, which is unacetylated at its NH2 terminus, binds F-actin weakly, and has a disabled Tmod-binding site Both Tmod and Tmod were effective at capping pointed ends of platelet ␤/cytoplasmic ␥ (␥cyto)-actin filaments coated with TM5NM1. Differences in TM binding by Tmod and Tmod do not appear to regulate the abilities of these Tmods to cap TM-␣sk-actin or TM-␤/␥cytoactin pointed ends and, are unlikely to determine selective co-assembly of Tmod, TM, and actin isoforms in different cell types and cytoskeletal structures. In a subset of its contexts, Tmod can be incorporated into a stable F-actin membrane skeleton in a manner similar to Tmod, such as on the lateral membranes of polarized epithelial cells [6] or in the sarcoplasmic reticulum (SR) of skeletal

The abbreviations used are
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call